Comments
Zydus Pharmaceuticals US’s subsidiary Nesher Pharmaceuticals on Monday informed final approval from the US drug regulator USFDA to market Oseltamivir Phosphate Capsules, USP in the US market.
Drug will be produced at the Nesher Pharmaceuticals manufacturing facility located in St. Louis, US. It is an anti-viral used in the prevention and treatment of influenza virus infection, it said here.
The drug, which will be marketed in the strengths of 30 mg, 45 mg and 75 mg, has the estimated sales of $382 million as per the IMS December 2016 (MAT).
The group now has nearly 110 approvals.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.